193. プラダー・ウィリ症候群 Prader-Willi syndrome Clinical trials / Disease details

臨床試験数 : 113 / 薬物数 : 111 - (DrugBank : 26) / 標的遺伝子数 : 48 - 標的パスウェイ数 : 102

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2007-006305-25-SE (EUCTR)	15/02/2008	03/01/2008	Effects of rimonabant (Acomplia) on obesity in adults with Prader-Willi Syndrome	Effects of rimonabant (Acomplia) on obesity in adults with Prader-Willi Syndrome	Obese adults with Prader Willi Syndrome MedDRA version: 9.1;Level: LLT;Classification code 10036476; ...	Trade Name: ACOMPLIA 20 mg film-coated tablets	Karolinska University Hospital	NULL	Not Recruiting			Female: yes Male: yes			Sweden
2	NCT00603109 (ClinicalTrials.gov)	August 2007	15/1/2008	Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome	Effect of Rimonabant, a Cannabinoid Receptor 1 Antagonist on Weight Gain and Body Composition in Adu ...	Prader-willi Syndrome	Drug: rimonabant;Drug: placebo	Weill Medical College of Cornell University	National Institutes of Health (NIH);PWSAUSA	Recruiting	18 Years	35 Years	Both	18	Phase 3	United States

First Previous1Next Last